05/01/2018
Oncologisch Centrum
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12. PMID: 29431193dr. Brouwers Barbaradr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe06/12/2023
Urologie
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
Genome Medicine; 2018 Nov 16;:1–13.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe09/12/2018
Urologie
TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer.
Clinical Cancer Research. 2018 Sep 12;clincanres.1943.2018.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe05/01/2018
Urologie
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
Prostate. 2018 May;78(6):435–45.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe06/12/2023
Urologie
Circulating tumour cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
Journal of Clinical Oncology. American Society of Clinical Oncology; 2017 May 20;35(15_suppl):5049–9.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe01/01/2013
Radiologie en Medische Beeldvorming
Model-Based Iterative Reconstruction and Adaptive Statistical Iterative Reconstruction techniques in abdominal CT: comparison of image quality in the detection of colorectal liver metastases.
Radiology 2013;269:469-474.dr. Bols Alaindr. Coenegrachts KennethGeen publicaties gevonden...